Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation.
作者信息
Nattel Stanley, Lip Gregory Y H, Filgueiras-Rama David, Dobrev Dobromir
机构信息
Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, 3655 Promenade Sir William Osler, Montreal QC, H3G 1Y6, Canada.
Department of Pharmacology and Therapeutics, McGill University, 5000 Belanger St E, Montreal, Quebec H1T 1C8, Canada.
出版信息
Cardiovasc Res. 2021 Jun 16;117(7):1609-1611. doi: 10.1093/cvr/cvab170.
Abstract
摘要
相似文献
1
Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation.
Cardiovasc Res. 2021 Jun 16;117(7):1609-1611. doi: 10.1093/cvr/cvab170.
2
From translation to integration: how to approach the complexity of atrial fibrillation mechanisms.
Cardiovasc Res. 2021 Jun 16;117(7):e88-e90. doi: 10.1093/cvr/cvab168.
3
Wide QRS Complexes in an Asymptomatic Elderly Man With Permanent Atrial Fibrillation.
Circulation. 2020 May 19;141(20):1656-1661. doi: 10.1161/CIRCULATIONAHA.120.046266. Epub 2020 May 18.
4
Long-term antiarrhythmic drug treatment after atrial fibrillation ablation: does a too obstinate rhythm control strategy bring serious risk of proarrhythmia to ablated patients?
Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):117-118. doi: 10.1093/ehjcvp/pvy043.
5
Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.
Cardiovasc Res. 2021 Jun 16;117(7):1616-1631. doi: 10.1093/cvr/cvab093.
6
Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):e002479. doi: 10.1161/CIRCEP.115.002479.
7
A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.
BMC Cardiovasc Disord. 2017 Jul 27;17(1):204. doi: 10.1186/s12872-017-0634-y.
8
Conduction gap across mitral isthmus line.
J Cardiovasc Electrophysiol. 2012 May;23(5):562-3. doi: 10.1111/j.1540-8167.2011.02136.x. Epub 2011 Aug 1.
9
Rhythm control for management of patients with atrial fibrillation: balancing the use of antiarrhythmic drugs and catheter ablation.
Clin Cardiol. 2011 Jan;34(1):23-9. doi: 10.1002/clc.20857.
10
Transmitral isthmus conduction alternans.
Heart Rhythm. 2012 Mar;9(3):470. doi: 10.1016/j.hrthm.2010.11.027. Epub 2010 Nov 18.
引用本文的文献
1
Cost-effectiveness of dabigatran for thromboembolic events prevention in atrial fibrillation patients in Chile.
Cost Eff Resour Alloc. 2025 Jul 7;23(1):34. doi: 10.1186/s12962-025-00642-8.
2
How synergy between mechanistic and statistical models is impacting research in atrial fibrillation.
Front Physiol. 2022 Aug 30;13:957604. doi: 10.3389/fphys.2022.957604. eCollection 2022.
3
Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC-derived atrial fibrillation model.
JCI Insight. 2022 Apr 8;7(7):e155640. doi: 10.1172/jci.insight.155640.
本文引用的文献
1
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs.
Eur Heart J Qual Care Clin Outcomes. 2022 Mar 2;8(2):187-194. doi: 10.1093/ehjqcco/qcaa093.
2
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.
Can J Cardiol. 2020 Dec;36(12):1847-1948. doi: 10.1016/j.cjca.2020.09.001. Epub 2020 Oct 22.
3
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
4
Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.
Circ Res. 2020 Jun 19;127(1):51-72. doi: 10.1161/CIRCRESAHA.120.316363. Epub 2020 Jun 18.
5
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.
Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19.
6
Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project.
Europace. 2019 Oct 1;21(10):1468-1475. doi: 10.1093/europace/euz141.
7
Cost of illness of atrial fibrillation: a nationwide study of societal impact.
BMC Health Serv Res. 2017 Nov 10;17(1):714. doi: 10.1186/s12913-017-2652-y.
8
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms.
Circ Res. 2014 Apr 25;114(9):1453-68. doi: 10.1161/CIRCRESAHA.114.303211.
9
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.
Eur Heart J. 2013 Sep;34(35):2746-51. doi: 10.1093/eurheartj/eht280. Epub 2013 Jul 30.
10
Vagal sensitivity and the production of auricular fibrillation in experimentally hyperthyroid dogs.
Am Heart J. 1953 May;45(5):781-9. doi: 10.1016/0002-8703(53)90320-2.
Zotero 插件